{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T22:32:00Z","timestamp":1793658720724,"version":"4.5.1"},"reference-count":86,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.lfs.2022.120374","type":"journal-article","created":{"date-parts":[[2022,2,4]],"date-time":"2022-02-04T11:17:21Z","timestamp":1643973441000},"page":"120374","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Impact of chronic obstructive pulmonary disease, lung infection, and\/or inhaled corticosteroids use on potential risk of lung cancer"],"prefix":"10.1016","volume":"294","author":[{"given":"Bansree","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronny","family":"Priefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.lfs.2022.120374_bb0025","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1378\/chest.14-2535","article-title":"Determinants of underdiagnosis of COPD in national and international surveys","volume":"148","author":"Lamprecht","year":"2015","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.lfs.2022.120374_bb0030","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/S2213-2600(17)30119-4","article-title":"Prognosis of asymptomatic and symptomatic, undiagnosed COPD in the general population in Denmark: a prospective cohort study","volume":"5","author":"\u00c7olak","year":"2017","journal-title":"Lancet Respir. Med."},{"issue":"2","key":"10.1016\/j.lfs.2022.120374_bb0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0193143","article-title":"Chronic obstructive pulmonary disease (COPD) as a disease of early aging: evidence from the EpiChron cohort","volume":"13","author":"Divo","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2022.120374_bb0040","doi-asserted-by":"crossref","unstructured":"L. Ang, P. Ghosh, W.J. Seow, (2021). Association between previous lung diseases and lung cancer risk: A systematic review and meta-analysis, Carcinogenesis (2021) (bgab082).","DOI":"10.1093\/carcin\/bgab082"},{"key":"10.1016\/j.lfs.2022.120374_bb0060","author":"Merhie"},{"key":"10.1016\/j.lfs.2022.120374_bb0065","author":"COPD"},{"issue":"1","key":"10.1016\/j.lfs.2022.120374_bb0070","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1378\/chest.07-2933","article-title":"COPD stage and risk of hospitalization for infectious disease","volume":"134","author":"Benfield","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.lfs.2022.120374_bb0075","doi-asserted-by":"crossref","unstructured":"M. Sandelin, S. Mindus, M. Thuresson, et. al., Factors associated with lung cancer in COPD patients, Int. J. Chron. Obstruct. Pulmon. Dis. 13 (2018) 1833\u20131839.","DOI":"10.2147\/COPD.S162484"},{"key":"10.1016\/j.lfs.2022.120374_bb0080","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.2147\/COPD.S121416","article-title":"Emerging pharmaceutical therapies for COPD","volume":"12","author":"Lakshmi","year":"2017","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"issue":"6","key":"10.1016\/j.lfs.2022.120374_bb0085","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1164\/rccm.201104-0597OC","article-title":"Acute exacerbations of chronic obstructive pulmonary disease","volume":"184","author":"Bafadhel","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"6","key":"10.1016\/j.lfs.2022.120374_bb0090","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1183\/09031936.00081409","article-title":"Infection as a comorbidity of COPD","volume":"35","author":"Sethi","year":"2010","journal-title":"Eur. Respir. J."},{"issue":"3","key":"10.1016\/j.lfs.2022.120374_bb0095","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1001\/archinternmed.2008.550","article-title":"Long-term use of inhaled corticosteroids and the risk of pneumonia in chronic obstructive pulmonary disease: a meta-analysis","volume":"169","author":"Singh","year":"2009","journal-title":"Arch. Intern. Med."},{"issue":"6","key":"10.1016\/j.lfs.2022.120374_bb0100","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1378\/chest.13-2137","article-title":"Use of inhaled corticosteroids in patients with COPD and the risk of TB and influenza: a systematic review and meta-analysis of randomized controlled trials","volume":"145","author":"Dong","year":"2014","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.lfs.2022.120374_bb0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0217289","article-title":"Assessment of lung function in successfully treated tuberculosis reveals high burden of ventilatory defects and COPD","volume":"14","author":"Gupte","year":"2019","journal-title":"PLoS One"},{"issue":"2018","key":"10.1016\/j.lfs.2022.120374_bb0110","doi-asserted-by":"crossref","first-page":"683","DOI":"10.2147\/COPD.S153555","article-title":"Early life insults as determinants of chronic obstructive pulmonary disease in adult life","volume":"13","author":"Savran","year":"2018","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"issue":"7","key":"10.1016\/j.lfs.2022.120374_bb0115","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1093\/aje\/kws151","article-title":"Previous lung diseases and lung cancer risk: a pooled analysis from the international lung cancer consortium","volume":"176","author":"Brenner","year":"2012","journal-title":"Am. J. Epidemiol."},{"issue":"1","key":"10.1016\/j.lfs.2022.120374_bb0120","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1186\/s12885-016-2838-4","article-title":"Post-inhaled corticosteroid pulmonary tuberculosis and pneumonia increases lung cancer in patients with COPD","volume":"16","author":"Wu","year":"2016","journal-title":"BMC Cancer"},{"issue":"5","key":"10.1016\/j.lfs.2022.120374_bb0125","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1093\/fampra\/cmt034","article-title":"Corticosteroids for acute and subacute cough following respiratory tract infection: a systematic review","volume":"30","author":"El-Gohary","year":"2013","journal-title":"Fam. Pract."},{"issue":"2","key":"10.1016\/j.lfs.2022.120374_bb0130","doi-asserted-by":"crossref","first-page":"1901720","DOI":"10.1183\/13993003.01720-2019","article-title":"Inhaled corticosteroid use and the incidence of lung cancer in COPD","volume":"55","author":"Suissa","year":"2019","journal-title":"Eur. Respir. J."},{"issue":"4","key":"10.1016\/j.lfs.2022.120374_bb0135","doi-asserted-by":"crossref","first-page":"1700451","DOI":"10.1183\/13993003.00451-2017","article-title":"Long-term effects of inhaled corticosteroids on sputum bacterial and viral loads in COPD","volume":"50","author":"Contoli","year":"2017","journal-title":"Eur. Respir. J."},{"issue":"9","key":"10.1016\/j.lfs.2022.120374_bb0140","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1164\/rccm.201206-1063PP","article-title":"Respiratory infection and the impact of pulmonary immunity on lung health and disease","volume":"186","author":"Mizgerd","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"2","key":"10.1016\/j.lfs.2022.120374_bb0145","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1017\/S095026889600725X","article-title":"Chlamydia pneumoniae infection in patients with chronic obstructive pulmonary disease","volume":"118","author":"von Hertzen","year":"1997","journal-title":"Epidemiol. Infect."},{"issue":"1","key":"10.1016\/j.lfs.2022.120374_bb0150","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.rmed.2004.04.014","article-title":"Chronic chlamydia pneumoniae infection is a risk factor for the development of COPD","volume":"99","author":"Brand\u00e9n","year":"2005","journal-title":"Respir. Med."},{"issue":"1","key":"10.1016\/j.lfs.2022.120374_bb0155","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s12931-015-0273-8","article-title":"Childhood pneumonia increases risk for chronic obstructive pulmonary disease: the copdgene study","volume":"16","author":"Hayden","year":"2015","journal-title":"Respir. Res."},{"key":"10.1016\/j.lfs.2022.120374_bb0160","doi-asserted-by":"crossref","first-page":"623e8","DOI":"10.1111\/j.1440-1843.2010.01749.x","article-title":"Tuberculosis, bronchiectasis and chronic airflow obstruction","volume":"15","author":"Jordan","year":"2010","journal-title":"Respirology"},{"key":"10.1016\/j.lfs.2022.120374_bb0165","doi-asserted-by":"crossref","first-page":"195e8","DOI":"10.1016\/S0954-6111(89)80031-9","article-title":"Chronic obstructive airways disease following treated pulmonary tuberculosis","volume":"83","author":"Willcox","year":"1989","journal-title":"Respir. Med."},{"issue":"2","key":"10.1016\/j.lfs.2022.120374_bb0170","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1183\/09031936.98.12020351","article-title":"Influence of antimicrobial chemotherapy on spirometric parameters and pro-inflammatory indices in severe pulmonary tuberculosis","volume":"12","author":"Plit","year":"1998","journal-title":"Eur. Respir. J."},{"issue":"1","key":"10.1016\/j.lfs.2022.120374_bb0175","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1136\/thorax.55.1.32","article-title":"Chronic pulmonary function impairment caused by initial and recurrent pulmonary tuberculosis following treatment","volume":"55","author":"Hnizdo","year":"2000","journal-title":"Thorax"},{"issue":"4","key":"10.1016\/j.lfs.2022.120374_bb0180","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1183\/13993003.02325-2014","article-title":"Tuberculosis associates with both airflow obstruction and low lung function: Bold results","volume":"46","author":"Amaral","year":"2015","journal-title":"Eur. Respir. J."},{"issue":"6","key":"10.1016\/j.lfs.2022.120374_bb0185","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.tube.2015.08.005","article-title":"TB meets COPD: an emerging global co-morbidity in human lung disease","volume":"95","author":"O\u2019Toole","year":"2015","journal-title":"Tuberculosis"},{"key":"10.1016\/j.lfs.2022.120374_bb0190","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.arcmed.2012.03.007","article-title":"Airflow obstruction in never smokers in five Latin American cities: the PLATINO study","volume":"43","author":"Perez-Padilla","year":"2012","journal-title":"Arch. Med. Res."},{"issue":"1","key":"10.1016\/j.lfs.2022.120374_bb0195","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1038\/s41598-020-79707-y","article-title":"Prevalence of different comorbidities in chronic obstructive pulmonary disease among Shahrekord PERSIAN cohort study in southwest Iran","volume":"11","author":"Kiani","year":"2021","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.lfs.2022.120374_bb0200","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1080\/08958378.2017.1346006","article-title":"Long-term use of inhaled corticosteroids and risk of upper respiratory tract infection in chronic obstructive pulmonary disease: a meta-analysis","volume":"29","author":"Yang","year":"2017","journal-title":"Inhal. Toxicol."},{"key":"10.1016\/j.lfs.2022.120374_bb0205","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.2147\/COPD.S164259","article-title":"Overuse of inhaled corticosteroids in COPD: five questions for withdrawal in daily practice","volume":"13","author":"Cataldo","year":"2018","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"issue":"2","key":"10.1016\/j.lfs.2022.120374_bb0210","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1517\/14656566.2016.1115482","article-title":"Adherence to current COPD guidelines in Turkey","volume":"17","author":"Turan","year":"2016","journal-title":"Expert. Opin. Pharmacother."},{"issue":"10","key":"10.1016\/j.lfs.2022.120374_bb0215","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0075221","article-title":"Overtreatment of COPD with inhaled corticosteroids \u2013 implications for safety and costs: cross-sectional observational study","volume":"8","author":"White","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.lfs.2022.120374_bb0220","doi-asserted-by":"crossref","first-page":"174","DOI":"10.4049\/jimmunol.1402217","article-title":"Glucocorticoid-augmented efferocytosis inhibits pulmonary pneumococcal clearance in mice by reducing alveolar macrophage bactericidal function","volume":"195","author":"Stolberg","year":"2015","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.lfs.2022.120374_bb0225","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1465-9921-7-53","article-title":"Role of apoptosis in the pathogenesis of COPD and pulmonary emphysema","volume":"7","author":"Demedts","year":"2006","journal-title":"Respir. Res."},{"key":"10.1016\/j.lfs.2022.120374_bb0230","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.4049\/jimmunol.1302138","article-title":"Chronic exposure to glucocorticoids shapes gene expression and modulates innate and adaptive activation pathways in macrophages with distinct changes in leukocyte attraction","volume":"192","author":"van de Garde","year":"2014","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.lfs.2022.120374_bb0235","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1164\/rccm.200611-1630OC","article-title":"Inhaled corticosteroid use in chronic obstructive pulmonary disease and the risk of hospitalization for pneumonia","volume":"176","author":"Ernst","year":"2007","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"3","key":"10.1016\/j.lfs.2022.120374_bb0240","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1183\/09031936.00193908","article-title":"Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: torch study results","volume":"34","author":"Crim","year":"2009","journal-title":"Eur. Respir. J."},{"issue":"2","key":"10.1016\/j.lfs.2022.120374_bb0245","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.rmed.2009.10.002","article-title":"Inhaled corticosteroids and risk of pneumonia in newly diagnosed COPD","volume":"104","author":"Joo","year":"2010","journal-title":"Respir. Med."},{"key":"10.1016\/j.lfs.2022.120374_bb0250","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2147\/COPD.S60498","article-title":"Risk of pneumonia with inhaled corticosteroid\/long-acting \u03b22 agonist therapy in chronic obstructive pulmonary disease: a cluster analysis","volume":"9","author":"DiSantostefano","year":"2014","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"10.1016\/j.lfs.2022.120374_bb0255","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.2147\/COPD.S116750","article-title":"The association between inhaled corticosteroid and pneumonia in COPD patients: the improvement of patients\u2019 life quality with COPD in Taiwan (impact) study","volume":"11","author":"Wang","year":"2016","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"issue":"1","key":"10.1016\/j.lfs.2022.120374_bb0260","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/MD.0b013e3181cafcd3","article-title":"Use of high-dose inhaled corticosteroids is associated with pulmonary tuberculosis in patients with chronic obstructive pulmonary disease","volume":"89","author":"Shu","year":"2010","journal-title":"Medicine"},{"issue":"5","key":"10.1016\/j.lfs.2022.120374_bb0265","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1164\/rccm.201007-1099OC","article-title":"Inhaled corticosteroids and risk of tuberculosis in patients with respiratory diseases","volume":"183","author":"Brassard","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"4","key":"10.1016\/j.lfs.2022.120374_bb0270","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1378\/chest.12-1225","article-title":"Inhaled corticosteroid is associated with an increased risk of TB in patients with COPD","volume":"143","author":"Kim","year":"2013","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.lfs.2022.120374_bb0275","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1378\/chest.13-2137","article-title":"Use of inhaled corticosteroids in patients with COPD and the risk of TB and influenza: a systematic review and meta-analysis of randomized controlled trials. A systematic review and meta-analysis of randomized controlled trials","volume":"145","author":"Dong","year":"2014","journal-title":"Chest"},{"key":"10.1016\/j.lfs.2022.120374_bb0280","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.2147\/COPD.S209273","article-title":"Inhaled corticosteroids and risk of tuberculosis in patients with obstructive lung diseases: a systematic review and meta-analysis of non-randomized studies","volume":"14","author":"Castellana","year":"2019","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"issue":"7","key":"10.1016\/j.lfs.2022.120374_bb0285","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1093\/aje\/kws151","article-title":"Previous lung diseases and lung cancer risk: a pooled analysis from the international lung cancer consortium","volume":"176","author":"Brenner","year":"2012","journal-title":"Am. J. Epidem."},{"issue":"4","key":"10.1016\/j.lfs.2022.120374_bb0290","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.revmed.2013.11.014","article-title":"Peut-on pr\u00e9venir ou gu\u00e9rir les cancers d\u2019origine infectieuse? [can we prevent or cure infection-related cancers?]","volume":"35","author":"Gisserot","year":"2014","journal-title":"Rev. Med. Interne"},{"issue":"2","key":"10.1016\/j.lfs.2022.120374_bb0295","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0148530","article-title":"Systems biology approaches for the prediction of possible role of chlamydia pneumoniae proteins in the etiology of lung cancer","volume":"11","author":"Khan","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2022.120374_bb0300","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1046\/j.1365-2796.2000.00742.x","article-title":"Infections as a major preventable cause of human cancer","volume":"248","author":"Kuper","year":"2000","journal-title":"J. Intern. Med."},{"issue":"1","key":"10.1016\/j.lfs.2022.120374_bb0305","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00408-013-9523-z","article-title":"Increased lung cancer risk among patients with pneumococcal pneumonia: a nationwide population-based cohort study","volume":"192","author":"Lin","year":"2013","journal-title":"Lung"},{"key":"10.1016\/j.lfs.2022.120374_bb0310","doi-asserted-by":"crossref","unstructured":"P. Zhan, L. Jun Suo, Q. Qian, et al., (2011). Chlamydia pneumoniae infection and lung cancer risk: a meta-analysis, Eur. J. Cancer 47 (5) (2011) 742\u2013747.","DOI":"10.1016\/j.ejca.2010.11.003"},{"issue":"4","key":"10.1016\/j.lfs.2022.120374_bb0315","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/joim.12270","article-title":"Pneumonia and the incidence of cancer: a Danish nationwide cohort study","volume":"277","author":"S\u00f8gaard","year":"2014","journal-title":"J. Int. Med."},{"issue":"3","key":"10.1016\/j.lfs.2022.120374_bb0320","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1177\/1534735403256332","article-title":"Inflammation as cause for scar cancers of the lung","volume":"2","author":"Ardies","year":"2003","journal-title":"Integr. Cancer Ther."},{"issue":"4","key":"10.1016\/j.lfs.2022.120374_bb0325","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/bjc.1987.233","article-title":"Lung cancer and prior tuberculosis infection in Shanghai","volume":"56","author":"Zheng","year":"1987","journal-title":"Br. J. Cancer"},{"issue":"6","key":"10.1016\/j.lfs.2022.120374_bb0330","first-page":"776","article-title":"Tuberculosis and lung cancer risk in nonsmoking women","volume":"125","author":"Hinds","year":"1982","journal-title":"Am. Rev. Respir. Dis."},{"issue":"12","key":"10.1016\/j.lfs.2022.120374_bb0335","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1002\/ijc.24636","article-title":"Facts and fiction of the relationship between preexisting tuberculosis and lung cancer risk: a systematic review","volume":"125","author":"Liang","year":"2009","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.lfs.2022.120374_bb0340","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/cncr.25616","article-title":"Pulmonary tuberculosis increases the risk of lung cancer: a population-based cohort study","volume":"117","author":"Wu","year":"2011","journal-title":"Cancer"},{"issue":"11","key":"10.1016\/j.lfs.2022.120374_bb0345","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1002\/ijc.30384","article-title":"Tuberculosis, smoking and risk for lung cancer incidence and mortality","volume":"139","author":"Hong","year":"2016","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.lfs.2022.120374_bb0350","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.lungcan.2014.07.001","article-title":"Latent TB infection in newly diagnosed lung cancer patients - a multicenter prospective observational study","volume":"85","author":"Fan","year":"2014","journal-title":"Lung cancer (Amsterdam, Netherlands)"},{"issue":"5","key":"10.1016\/j.lfs.2022.120374_bb0355","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0250531","article-title":"Increased risk of secondary lung cancer in patients with tuberculosis: a nationwide, population-based cohort study","volume":"16","author":"Ho","year":"2021","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.lfs.2022.120374_bb0360","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1378\/chest.128.4.1895","article-title":"Are COPD and lung cancer two manifestations of the same disease?","volume":"128","author":"Petty","year":"2005","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.lfs.2022.120374_bb0365","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1513\/pats.200603-089MS","article-title":"State of the art. Chronic obstructive pulmonary disease, inflammation, and lung cancer","volume":"3","author":"Brody","year":"2006","journal-title":"Proc. Am. Thorac. Soc."},{"issue":"4","key":"10.1016\/j.lfs.2022.120374_bb0370","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nrc3477","article-title":"Mechanistic links between COPD and lung cancer","volume":"13","author":"Houghton","year":"2013","journal-title":"Nat. Rev. Cancer"},{"issue":"11","key":"10.1016\/j.lfs.2022.120374_bb0375","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000014837","article-title":"Does chronic obstructive pulmonary disease relate to poor prognosis in patients with lung cancer?","volume":"98","author":"Lin","year":"2019","journal-title":"Medicine"},{"issue":"7","key":"10.1016\/j.lfs.2022.120374_bb0380","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1164\/rccm.200608-1125OC","article-title":"Inhaled corticosteroids and risk of lung cancer among patients with chronic obstructive pulmonary disease","volume":"175","author":"Parimon","year":"2007","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.lfs.2022.120374_bb0385","first-page":"587","article-title":"Effects of inhaled corticosteroids on airway inflammation in chronic obstructive pulmonary disease: a systematic review and meta-analysis","volume":"7","author":"Jen","year":"2012","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"issue":"41","key":"10.1016\/j.lfs.2022.120374_bb0390","doi-asserted-by":"crossref","first-page":"17117","DOI":"10.1073\/pnas.1114420108","article-title":"Tumor suppressor protein (p)53, is a regulator of NF-kappaB repression by the glucocorticoid receptor","volume":"108","author":"Murphy","year":"2011","journal-title":"PNAS USA"},{"issue":"9","key":"10.1016\/j.lfs.2022.120374_bb0395","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/mc.22029","article-title":"Differential effects on lung cancer cell proliferation by agonists of glucocorticoid and PPAR\u0391 receptors","volume":"53","author":"Liang","year":"2013","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.lfs.2022.120374_bb0400","doi-asserted-by":"crossref","first-page":"533","DOI":"10.2147\/COPD.S63911","article-title":"A randomized controlled trial of inhaled corticosteroids (ICS) on markers of epithelial\u2013mesenchymal transition (EMT) in large airway samples in COPD: an exploratory proof of concept study","volume":"9","author":"Sohal","year":"2014","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"issue":"1","key":"10.1016\/j.lfs.2022.120374_bb0405","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.rmed.2008.07.024","article-title":"Inhaled corticosteroids and risk of lung cancer among COPD patients who quit smoking","volume":"103","author":"Kiri","year":"2009","journal-title":"Respir. Med."},{"issue":"146","key":"10.1016\/j.lfs.2022.120374_bb0410","article-title":"Is mitochondrial dysfunction a driving mechanism linking COPD to nonsmall cell lung carcinoma?","volume":"26","author":"Kwong","year":"2017","journal-title":"Eur. Respir. Rev."},{"issue":"S17","key":"10.1016\/j.lfs.2022.120374_bb0415","doi-asserted-by":"crossref","DOI":"10.21037\/jtd.2019.10.54","article-title":"Chronic obstructive pulmonary disease (COPD) and lung cancer: common pathways for pathogenesis","volume":"11","author":"Parris","year":"2019","journal-title":"J. Thorac. Dis."},{"issue":"7","key":"10.1016\/j.lfs.2022.120374_bb0420","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0159683","article-title":"Post-inhaled corticosteroid pulmonary tuberculosis increases lung cancer in patients with asthma","volume":"11","author":"Jian","year":"2016","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.lfs.2022.120374_bb0425","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1002\/ijc.31632","article-title":"Inhaled corticosteroids in COPD and the risk of lung cancer","volume":"143","author":"Lee","year":"2018","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.lfs.2022.120374_bb0430","first-page":"61","article-title":"Do inhaled corticosteroids protect against lung cancer in patients with COPD?","volume":"22","author":"Raymakers","year":"2016","journal-title":"A systematic review, Respirology"},{"issue":"2","key":"10.1016\/j.lfs.2022.120374_bb0435","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13434","article-title":"Inhaled corticosteroids and risk of lung cancer: a systematic review and meta-analysis","volume":"51","author":"Lin","year":"2020","journal-title":"Eur. J. Clin. Investig."},{"issue":"2","key":"10.1016\/j.lfs.2022.120374_bb0440","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00408-018-0092-z","article-title":"Use of inhaled corticosteroids and the risk of lung cancer, the hunt study","volume":"196","author":"S\u00f8rli","year":"2018","journal-title":"Lung"},{"issue":"3","key":"10.1016\/j.lfs.2022.120374_bb0445","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.21037\/tlcr-20-1126","article-title":"Inhaled corticosteroids and risk of lung cancer among chronic obstructive pulmonary disease patients: a comprehensive analysis of nine prospective cohorts","volume":"10","author":"Ge","year":"2021","journal-title":"Transl. Lung Cancer Res."},{"key":"10.1016\/j.lfs.2022.120374_bb0450","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.rmed.2009.10.024","article-title":"Responses to inhaled long-acting beta-agonist and corticosteroid according to COPD subtype","volume":"104","author":"Lee","year":"2010","journal-title":"Respir. Med."},{"issue":"1","key":"10.1016\/j.lfs.2022.120374_bb0455","doi-asserted-by":"crossref","DOI":"10.1038\/npjpcrm.2016.68","article-title":"Appropriate use of inhaled corticosteroids in COPD: the candidates for safe withdrawal","volume":"26","author":"Yawn","year":"2016","journal-title":"NPJ Prim. Care. Respir. Med."},{"issue":"2","key":"10.1016\/j.lfs.2022.120374_bb0470","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1183\/09031936.00144208","article-title":"COPD prevalence is increased in lung cancer, independent of age, sex and smoking history","volume":"34","author":"Young","year":"2009","journal-title":"Eur. Respir. J."},{"issue":"160","key":"10.1016\/j.lfs.2022.120374_bb0475","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0075-2021","article-title":"Systematic review on long-term adverse effects of inhaled corticosteroids in the treatment of COPD","volume":"30","author":"Miravitlles","year":"2021","journal-title":"Eur. Respir. Rev."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320522000741?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320522000741?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T20:55:47Z","timestamp":1758401747000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320522000741"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":86,"alternative-id":["S0024320522000741"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2022.120374","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of chronic obstructive pulmonary disease, lung infection, and\/or inhaled corticosteroids use on potential risk of lung cancer","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2022.120374","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"120374"}}